IMMX Immix Biopharma, Inc.

NASDAQ
$7.84

Immix Biopharma, Inc. (IMMX) SEC Filings

Everything IMMX has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

41 filings
Date Form Filing
8-K Earnings Release · Executive Change · Other
10-Q
SCHEDULE 13G
8-K Capital Raise · Other Event
8-K Other · Other Event · Reg Fd
10-Q
4
4
4
4
4
4
4
4
4
10-Q
10-K/A
10-K
4
4
4
10-Q
4
4
10-Q
10-Q/A
10-K/A
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.